Journal
HAUTARZT
Volume 56, Issue 12, Pages 1144-+Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00105-005-0953-2
Keywords
atopic eczema; cost-of-illness study; disease severity
Categories
Ask authors/readers for more resources
Background. Atopic eczema is one of the most common skin diseases. In Germany, the economic burden is estimated to be EUR 1.2-3.5 billion yearly. The aim of this study was to show the resource utilization and costs for outpatient care and the out-of-pocket expenses for the patients. Patients and methods. This study was a multi-center, retrospective and prospective cost-of-illness study. Patient characteristics and data on resource utilization were collected with a semi-structured patient questionnaire and by chart abstraction. 193 patients filled in the patient questionnaire; data from 169 patients were obtained by chart abstraction. Results. Average direct medical costs of a disease flare were EUR 123 per patient. Average annual total costs were EUR 1,425 per patient, increasing with severity from EUR 956 (mild) to EUR 2,068 (severe). Conclusion. Prolongation of flare-free time and reduction in severity are not only desirable for the patients but also of economic interest.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available